SomnoMed Limited (ASX:SOM)
Australia · Delayed Price · Currency is AUD 0.3500
+0.0150 (4.48%)
Sep 16, 2026, 2:50 PM AEST
SomnoMed Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, SomnoMed stock has a consensus rating of "Strong Buy" and an average price target of $0.84. The average 1-year stock price forecast is 140.00% higher than the current stock price, while the lowest is $0.76 (+117.14%) and the highest is $0.99 (+182.86%).
Price Target: $0.84 (+140.00%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for SomnoMed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $0.76 | Buy | Maintains | $0.76 | +117.14% | Aug 31, 2026 |
| Morgans | Morgans | Buy Maintains $0.75 → $0.76 | Buy | Maintains | $0.75 → $0.76 | +117.14% | Aug 31, 2026 |
Financial Forecast
Revenue This Year
121.90M
from 114.53M
Increased by 6.43%
Revenue Next Year
130.84M
from 121.90M
Increased by 7.33%
EPS This Year
0.02
from -0.01
EPS Next Year
0.02
from 0.02
Increased by 21.27%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.